{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T11:13:26Z","timestamp":1768216406317,"version":"3.49.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The choice of first-line therapy for community-acquired pneumonia (CAP) depends on disease severity. However, quickly and accurately differentiating mild from severe CAP patients remains challenging. This study aims to evaluate the performance of machine learning-based diagnostic models employing routine blood indicators to distinguish CAP severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicenter, retrospective, case\u2013control study conducted at Xuhui Central Hospital (Discovery cohort), and Putuo People\u2019s Hospital (Validation cohort), from January 2016 to January 2024. Patients were further classified into mild or severe CAP according to the IDSA\/ATS criteria. Routine blood tests were performed with an automatic blood cell analyzer. Twelve machine learning-based diagnostic models were developed from routine blood indicators for differentiating between mild and severe CAP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3,127 (1,612 mild, 1,615 severe) and 2,087 participants (1,072 mild, 1,015 severe) were included in the discovery and validation cohorts, respectively. Of the 12 models developed, the random forest (RF) model showed the best performance with 9 routine blood indicators. In the discovery cohort, the model achieved an AUC of 0.95, an AUPRC of 0.94, a positive predictive value of 0.89, a negative predictive value of 0.88, an accuracy of 0.89, and an F1 score of 0.89, while in the validation cohort, it demonstrated similar performance, with values of 0.95, 0.94, 0.88, 0.87, 0.88, and 0.87, respectively. Decision curve analysis confirmed consistent net benefits from the model across all threshold probabilities. The RF model was integrated into a web application for clinical use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We successfully developed a nine-feature RF model with promising value for differentiating mild from severe CAP patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2025.1605502","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:13:53Z","timestamp":1768205633000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A machine learning-based model for assessing community-acquired pneumonia severity using routine blood tests"],"prefix":"10.3389","volume":"15","author":[{"given":"Chao","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(21)00630-9","article-title":"Community-acquired pneumonia","volume":"398","author":"Aliberti","year":"2021","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13052-025-01989-7","article-title":"Advanced biomarkers for prognostic evaluation of pneumonia severity in pediatric intensive care: focus on novel inflammatory and hematological ratios","volume":"51","author":"Ari","year":"2025","journal-title":"Ital. J. Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.21037\/atm.2016.10.73","article-title":"Clinical significance of cell population data (CPD) on Sysmex XN-9000 in septic patients with our without liver impairment","volume":"4","author":"Buoro","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1136\/thx.2009.133280","article-title":"Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis","volume":"65","author":"Chalmers","year":"2010","journal-title":"Thorax"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120367","article-title":"Development and validation of a machine learning model based on complete blood counts to predict clinical outcomes in urothelial carcinoma patients","volume":"575","author":"Cheng","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.2147\/JIR.S342272","article-title":"Association between pre-treatment and post-treatment 3-month red cell distribution width with three-year prognosis of prostate cancer","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Inflammation Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/CCM.0000000000003799","article-title":"Monocyte distribution width: A novel indicator of sepsis-2 and sepsis-3 in high-risk emergency department patients","volume":"47","author":"Crouser","year":"2019","journal-title":"Crit. Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1503\/cmaj.190952","article-title":"Complementing chronic frailty assessment at hospital admission with an electronic frailty index (FI-Laboratory) comprising routine blood test results","volume":"192","author":"Ellis","year":"2020","journal-title":"CMAJ"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/thx.2008.109785","article-title":"New perspectives on community-acquired pneumonia in 388\u2013406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality","volume":"64","author":"Ewig","year":"2009","journal-title":"Thorax"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/qjmed\/hcw110","article-title":"Using routine blood test results to predict the risk of death for emergency medical admissions to hospital: an external model validation study","volume":"110","author":"Faisal","year":"2017","journal-title":"QJM"},{"key":"B11","doi-asserted-by":"publisher","first-page":"00420","DOI":"10.1183\/23120541.00420-2024","article-title":"Biomarkers troponin and procalcitonin in addition to CRB-65 enhance risk stratification in patients with community-acquired pneumonia","volume":"10","author":"Farhat","year":"2024","journal-title":"ERJ. Open Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10096-022-04416-5","article-title":"Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool","volume":"41","author":"Gl\u00f6ckner","year":"2022","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2022.211255","article-title":"A new prediction model for prolonged hospitalization in adult community-acquired pneumonia (CAP) patients","volume":"68","author":"Liu","year":"2022","journal-title":"Clin. Lab."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/srep22911","article-title":"Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2022.109445","article-title":"Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission","volume":"179","author":"Mao","year":"2023","journal-title":"Radiother. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1136\/thx.2009.118612","article-title":"Stability in community-acquired pneumonia: one step forward with markers","volume":"64","author":"Men\u00e9ndez","year":"2009","journal-title":"Thorax"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the american thoracic society and infectious diseases society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.2147\/JIR.S512632","article-title":"Dynamic trends of albumin-to-C-reactive protein ratio: A prognostic indicator in elderly patients with community-acquired pneumonia","volume":"18","author":"Miao","year":"2025","journal-title":"J. Inflammation Res."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.639174","article-title":"Evaluation of host serum protein biomarkers of tuberculosis in sub-saharan africa","volume":"12","author":"Morris","year":"2021","journal-title":"Front. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1056\/NEJMra1312885","article-title":"Community-acquired pneumonia","volume":"371","author":"Musher","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1186\/s12913-024-11612-w","article-title":"Benefits of emergency department routine blood test performance on patients whose allocated triage category is not time critical: a retrospective study","volume":"24","author":"Osman","year":"2024","journal-title":"BMC Health Serv. Res."},{"key":"B23","unstructured":"The top 10 causes of death"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102909","article-title":"A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children","volume":"58","author":"Togun","year":"2020","journal-title":"EBioMedicine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/jama.2024.14796","article-title":"Community-acquired pneumonia: A review","volume":"332","author":"Vaughn","year":"2024","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejim.2017.02.013","article-title":"A new method to predict hospital mortality in severe community acquired pneumonia","volume":"40","author":"Wang","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12859-022-04926-1","article-title":"Clinlabomics: leveraging clinical laboratory data by data mining strategies","volume":"23","author":"Wen","year":"2022","journal-title":"BMC Bioinf."},{"key":"B28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejim.2021.10.030","article-title":"Neutrophil count, lymphocyte count and neutrophil-to-lymphocyte ratio in relation to response to adjunctive dexamethasone treatment in community-acquired pneumonia","volume":"96","author":"Wittermans","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.58600\/eurjther1976","article-title":"Evaluation of the relationship between biomarkers and disease severity in patients with community-acquired pneumonia","volume":"30","author":"Ye\u015filda\u011f","year":"2024","journal-title":"Eur. J. Ther."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154614","article-title":"The prediction of lymphocyte count and neutrophil count on the efficacy of Xuebijing adjuvant treatment for severe community-acquired pneumonia: A post hoc analysis of a randomized controlled trial","volume":"110","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.21037\/atm-22-3491","article-title":"A new haematological model for the diagnosis and prognosis of severe community-acquired pneumonia: a single-center retrospective study","volume":"10","author":"Zheng","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s11739-024-03699-0","article-title":"Association of serum interleukin-2 with severity and prognosis in hospitalized patients with community-acquired pneumonia: a prospective cohort study","volume":"19","author":"Zhu","year":"2024","journal-title":"Intern. Emerg. Med."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1605502\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:13:54Z","timestamp":1768205634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1605502\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":32,"alternative-id":["10.3389\/fcimb.2025.1605502"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1605502","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1605502"}}